NCT00141180View on ClinicalTrials.gov

CP-481,715 Nickel Allergy Study.

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

October 31, 2005

Conditions
Dermatitis, Allergic Contact
Interventions
DRUG

CP-481,715

Trial Locations (5)

2900

Pfizer Investigational Site, Hellerup

10032

Pfizer Investigational Site, New York

77802

Pfizer Investigational Site, Bryan

78759

Pfizer Investigational Site, Austin

48109-0314

Pfizer Investigational Site, Ann Arbor

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY